Retatrutide has emerged as a new treatment in the fight against obesity. This groundbreaking drug, categorized as a dual GLP-1 and GIP receptor agonist, shows promising results in clinical trials. By boosting these https://sabrinaavul545727.csublogs.com/43405922/retatrutide-a-promising-new-treatment-for-obesity